PsychoactiveMap

University of Iowa Health Care psychedelic research trials

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

University of Iowa Health Care is listed with 3 registered studies counted here, in Iowa City, United States. By compound: 1 psilocybin and 3 ketamine. By registry status: 3 recruiting. By phase: 2 phase 2 and 1 not reported. Reported start years run from 2014 (earliest) to 2025 (latest).

Institution name, city and country are copied from the research site linked to each registry record. A study counts once per institution, and a study tagged with more than one compound is counted under each compound.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

By compound

Compound hubStudies
Psilocybin1
Ketamine3

By registry status

StatusStudiesShare
Recruiting3100%

By phase

PhaseStudiesShare
Phase 2267%
Not reported133%

Registered studies

All counted studies, newest start first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Title as registeredRegistry IDStatusPhaseRegistry datesCompound
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator TrialNCT06405607RecruitingPhase 2Source start: 2025-06-12 (actual)
Source date details

Start: 2025-06-12 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-04 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-04 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.400Z; registry revision: 2025-11-28 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Psilocybin, Ketamine
University of Iowa Interventional Psychiatry Service Patient RegistryNCT04480918RecruitingNot reportedSource start: 2020-11-02 (actual)
Source date details

Start: 2020-11-02 (precision: day; source type: ACTUAL; actual)

Primary completion: 2050-08 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2050-08 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:15.458Z; registry revision: 2026-03-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ketamine
Ketamine Alcohol (in Treatment-Resistant Depression)NCT02122562RecruitingPhase 2Source start: 2014-04-23 (type unknown)
Source date details

Start: 2014-04-23 (precision: day; source type: not reported; unknown)

Primary completion: 2028-09 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-09 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:13.506Z; registry revision: 2026-05-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ketamine

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.

Substance hubs for these compounds

Psilocybin | Ketamine

Country hub: United States

All trial hubs | Learn | Disclaimer